NCIRS has available a recording of a webinar on the New shingles vaccine on Australia’s NIP (National Immunisation Program) NIP) Shingrix®, which on 1 November 2023 replaced Zostavax® for eligible people most at risk of complications from shingles (herpes zoster).
Leading experts presented on:
- the disease burden of shingles in Australia
- details about Shingrix®, including clinical trial results and mechanism of protection
- the new Australian Shingrix®vaccination program, including eligibility for NIP-funded vaccine, with a focus on older people, people with immunocompromise and Aboriginal and Torres Strait Islander peoples
- the US experience of implementing a national Shingrix
Resources:
- Zoster vaccines (Shingrix® [RZV] and Zostavax® [ZVL]) – Frequently asked questions
- Australian Government Department of Health and Aged Care resources
- Australian Government Department of Health and Aged Care resources for Aboriginal and Torres Strait Islander peoples
TO VIEW THE INDIVIDUAL RECORDINGS CLICK HERE
AND
Vaccination for people with disability
In this webinar we explored gaps, opportunities and advice relating to vaccinating people with disability.
Our expert panel of leading researchers and clinicians presented on:
- vaccine coverage and vaccination service gaps for people with disability
- tips and strategies for vaccinating people with disability in your clinic
- ways to support vaccination of patients with complex needs
- new NCIRS resources to support health care providers in vaccination
Related resource: Immunisation for individuals with additional needs – Practical guide